Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-23

Clinical Trial Update: Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating continuous IV infusion of ketorolac for moderately severe postoperative pain after bunionectomy has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Neumentum, Inc. | Conditions: Pain, Postoperative | Phase 3 | Status: SUSPENDED